Kiniksa Pharmaceuticals International (KNSA) Cash & Equivalents (2017 - 2026)
Kiniksa Pharmaceuticals International (KNSA) posted Cash & Equivalents of $175.68 million for Q2 2026, down 8.5% from $192.04 million a year earlier and down 7.5% from the prior quarter.
Powered by 
Analysis
Kiniksa Pharmaceuticals International (KNSA) Cash & Equivalents (2017 - 2026) Analysis & Trends
At the end of FY2025, Kiniksa Pharmaceuticals International's Cash & Equivalents came in at $165.6 million, down 9.8% from FY2024.
- Annual Cash & Equivalents shows a five-year compound annual growth rate of 7.7% (FY2020 to FY2025).
- In prior years, Kiniksa Pharmaceuticals International's Cash & Equivalents was $183.58 million in FY2024 (+70.1%), $107.95 million in FY2023 (-12.0%), $122.72 million in FY2022 (+0.2%) and $122.47 million in FY2021 (+7.4%).
- Quarterly Cash & Equivalents has run from a low of $63.32 million in Q1 2022 to a high of $192.04 million in Q2 2025 over five years.
- On a year-over-year basis, Cash & Equivalents increased in five of the last eight quarters, with growth averaging 30.0%.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q3 2021, with growth of 120.9%; the weakest was Q1 2022, with a decline of 47.2%.
- According to Business Quant data, Cash & Equivalents for the three prior quarters was $189.95 million (Q1 2026), $165.6 million (Q4 2025) and $174.86 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Kiniksa Pharmaceuticals International | 11.82 Bn | 10.56 Bn | 220.03 Mn | 175.68 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 175.68 Mn |
| Mar 31, 2026 | 189.95 Mn |
| Dec 31, 2025 | 165.60 Mn |
| Sep 30, 2025 | 174.86 Mn |
| Jun 30, 2025 | 192.04 Mn |
| Mar 31, 2025 | 157.13 Mn |
| Dec 31, 2024 | 183.58 Mn |
| Sep 30, 2024 | 97.38 Mn |
| Jun 30, 2024 | 99.27 Mn |
| Mar 31, 2024 | 141.08 Mn |
| Dec 31, 2023 | 107.95 Mn |
| Sep 30, 2023 | 117.83 Mn |
| Jun 30, 2023 | 112.57 Mn |
| Mar 31, 2023 | 80.62 Mn |
| Dec 31, 2022 | 122.72 Mn |
| Sep 30, 2022 | 175.76 Mn |
| Jun 30, 2022 | 94.31 Mn |
| Mar 31, 2022 | 63.32 Mn |
| Dec 31, 2021 | 122.47 Mn |
| Sep 30, 2021 | 190.18 Mn |
API Access
Kiniksa Pharmaceuticals International Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=KNSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "KNSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=KNSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();